Navigation Links
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion
Date:4/27/2011

ility and edema and prevent the inappropriate growth of new blood vessels in the retina in patients with CRVO.

About VEGF Trap-Eye

VEGF Trap-Eye is a fully human fusion protein, consisting of soluble VEGF receptors 1 and 2, that binds all forms of VEGF-A along with the related Placental Growth Factor (PlGF).  VEGF Trap-Eye is a specific and highly potent blocker of these growth factors.  VEGF Trap-Eye is specially purified and contains iso-osmotic buffer concentrations, allowing for injection into the eye.

Bayer HealthCare and Regeneron are collaborating on the global development of VEGF Trap-Eye for the treatment of the neovascular form of age related macular degeneration (wet AMD), central retinal vein occlusion (CRVO), diabetic macular edema (DME), and other eye diseases and disorders.

Regeneron submitted a Biologics License Application (BLA) for marketing approval in wet AMD in the U.S. in February 2011 and received a Priority Review designation.  Under Priority Review, the target date for an FDA decision on the VEGF Trap-Eye BLA is August 20, 2011. Bayer plans to file regulatory submissions in Europe in the second quarter of 2011.

In April 2011, Bayer HealthCare and Regeneron announced the initiation of a Phase 3 program in DME.

Bayer HealthCare will market VEGF Trap-Eye outside the United States, where the companies will share equally the profits from any future sales of VEGF Trap-Eye.  Regeneron maintains exclusive rights to VEGF Trap-Eye in the United States.

About Regeneron Pharmaceuticals

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions.  In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in Phase 3 clinical trials for the potential treatment of gout, disease
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
2. Regeneron Announces Presentation at the 10th Annual Needham Healthcare Conference
3. Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
4. Regeneron Announces March 2011 Investor Conference Presentations
5. Regeneron Submits Biologics License Application to FDA for VEGF Trap-Eye for Treatment of Wet Age-Related Macular Degeneration
6. Regeneron Reports Full Year and Fourth Quarter 2010 Financial and Operating Results
7. Regeneron to Webcast Investor Briefing on VEGF Trap-Eye Clinical Program on Sunday, February 13th at 9 am ET
8. Regeneron Announces Presentation at the ISI Annual Conference
9. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
10. Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME)
11. Christine A. Poon Elected to Regeneron Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... -- ReportsnReports.com adds Global Medical Simulation ... as well as Global Medical Simulation Market 2015-2019 ... of its library. Complete 2015 report ... across 164 pages, talking about 7 major companies ... now available at http://www.reportsnreports.com/reports/407046-global-medical-simulation-industry-report-2015.html . ...
(Date:8/3/2015)... Aug. 3, 2015  Sage Analytics ( www.sageanalytics.com ), ... cannabis potency measurement systems, announced its sponsorship of the ... Fundraiser. A limited number of tickets are available for ... a great cause while enjoying an open bar, buffet ... the San Francisco Bay at sunset. With ...
(Date:8/3/2015)... Aug. 3, 2015   ConvergeHEALTH by ... Allergan plc is expanding its year-long ... Intermountain Healthcare to include women,s health.  ... analytics platform to generate real-world clinical insights in ... "We look forward to expanding our work with ...
Breaking Medicine Technology:Medical Simulation Market to see 14% CAGR to 2019 2Medical Simulation Market to see 14% CAGR to 2019 3Medical Simulation Market to see 14% CAGR to 2019 4Medical Simulation Market to see 14% CAGR to 2019 5Medical Simulation Market to see 14% CAGR to 2019 6Sage Analytics Sponsors California Cannabis Industry Association Bay Area Cruise FUNdraiser 2ConvergeHEALTH by Deloitte and Intermountain Healthcare Expand Real World Evidence Collaboration with Allergan to Focus on Women's Health 2ConvergeHEALTH by Deloitte and Intermountain Healthcare Expand Real World Evidence Collaboration with Allergan to Focus on Women's Health 3ConvergeHEALTH by Deloitte and Intermountain Healthcare Expand Real World Evidence Collaboration with Allergan to Focus on Women's Health 4
... Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced ... as Vice President of Quality.  In this newly created ... Machielse, Mr. Maines will be responsible for Quality, Validation ... Maines brings to the Company more than 25 years ...
... Reportlinker.com announces that a new market ... Global Eyeglasses Industry ... This report analyzes the worldwide markets for ... by the following Product Segments: Lenses, Frames ...
Cached Medicine Technology:Timothy J. Maines Joins Omthera Pharmaceuticals as Vice President of Quality 2Global Eyeglasses Industry 2Global Eyeglasses Industry 3Global Eyeglasses Industry 4Global Eyeglasses Industry 5Global Eyeglasses Industry 6Global Eyeglasses Industry 7Global Eyeglasses Industry 8Global Eyeglasses Industry 9Global Eyeglasses Industry 10Global Eyeglasses Industry 11Global Eyeglasses Industry 12Global Eyeglasses Industry 13
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... as one of 20 finalists for America’s Favorite Veterinarian. The contest is put ... by a judging committee from 500 nominees. Nominees were evaluated on community involvement, ...
(Date:8/4/2015)... ... 04, 2015 , ... The Law Offices of Ben C. Martin , ... with Inferior Vena Cava Filters (“IVC Filters”). , As lead IVC filter lawyer for ... Filter clients under In re Cook Medical, Inc., IVC Filters Marketing, Sales Practices and ...
(Date:8/4/2015)... Louis, MO (PRWEB) , ... August 04, 2015 ... ... attorneys handling national talcum powder lawsuits filed against Johnson & Johnson report that ... Talcum powder lawyers provide regular news updates and cancer warning information ...
(Date:8/4/2015)... ... August 04, 2015 , ... Continuing ... in support of an interaction simulation session entitled "NOACS: What the Evidence Shows ... by Medical Learning Institute Inc. and EDUmotion US LLC. , This special activity ...
(Date:8/4/2015)... ... 2015 , ... Lightning Labels is pleased to announce the ... usher in a new standard of sticker and label-making for the company. , ... twin objectives of quality and quantity without compromising the signature lightning-fast speed we ...
Breaking Medicine News(10 mins):Health News:Dr. Gary Richter, Oakland Holistic Veterinarian, Among 20 Finalists for America’s Favorite Veterinarian 2Health News:Dr. Gary Richter, Oakland Holistic Veterinarian, Among 20 Finalists for America’s Favorite Veterinarian 3Health News:Law Offices of Ben C. Martin in Dallas Files New IVC Filter Complications Lawsuits and Pursues Settlements 2Health News:Law Offices of Ben C. Martin in Dallas Files New IVC Filter Complications Lawsuits and Pursues Settlements 3Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 2Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 3Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 4Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 2Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 3Health News:Lightning Labels Installs State-of-the-Art Digital Press 2Health News:Lightning Labels Installs State-of-the-Art Digital Press 3
... Medical University ... epidural prefrontal cortical stimulation , CHARLESTON, S.C., Oct. 13 ... with treatment-resistant depression. Bilateral epidural prefrontal cortical stimulation (EpCS) was ... in a small group of patients, according to lead researcher ...
... Package Continues to Provide Daily Requirement of Milk and ... The following was issued today by the Dairy Council ... available to WIC participants has garnered public attention, it ... continue to be strongly supported nutrient-rich options in this ...
... October marks Domestic Violence Awareness month and on October ... professionals across the country will reflect on over 800 ... restored by the American Academy of Cosmetic Dentistry Charitable ... (Photo: http://www.newscom.com/cgi-bin/prnh/20091013/DC91525 ) , ...
... invasive procedures (including the use of robotic assistance) for ... may shorten hospital stays and decrease respiratory and surgical ... of certain complications, including incontinence and erectile dysfunction, according ... JAMA , a theme issue on surgical care. ...
... 13, 2009 Early action, especially rapid rollout of vaccines, ... H1N1 influenza virus, according to a simulation model of a ... CMAJ ( Canadian Medical Association Journal ) ... that projects how many people will be infected under different ...
... finds better short-term results for endovascular repair than for ... A less-invasive method of abdominal aortic aneurysm (AAA) repair ... new U.S. study. , The interim findings are from ... and open surgical repair of AAA. The report included ...
Cached Medicine News:Health News:New Brain Stimulation Treatment May Offer Hope For Those With Treatment Resistant Depression 2Health News:New Brain Stimulation Treatment May Offer Hope For Those With Treatment Resistant Depression 3Health News:With All the Focus on What's New, Milk Remains Tried and True 2Health News:Over 800 Lives of Domestic Violence Survivors Restored by the American Academy of Cosmetic Dentistry Charitable Foundation's Give Back A Smile Program 2Health News:Minimally invasive radical prostatectomy shows advantages, but also certain complications 2Health News:H1N1 simulation modeling shows rapid vaccine rollout effective in reducing infection rates 2Health News:Study Compares Abdominal Aortic Aneurysm Repair Methods 2
The Gizmo male external catheter is a latex catheter that uses a single-sided adhesive strip....
... Medical's line of Personal ... catheters you would choose ... product configurations - standard, ... hydro - are based ...
Active Cath is a latex, self-adhering, one piece catheter designed for extended wear. It combines a shortened latex sheath with a wide adhesive seal....
The Freedom Clear® LS Long Seal is a 100% latex-free, self-adhering, one piece catheter with an ultra-thin sheath for everyday wear. Its long seal provides added security....
Medicine Products: